Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study

dc.creatorSilva, Thiago Cerqueira
dc.creatorAndrews, Jason R.
dc.creatorBoaventura, Viviane S.
dc.creatorRanzani, Otavio T.
dc.creatorOliveira, Vinicius de Araújo
dc.creatorPaixão, Enny S.
dc.creatorBertoldo Júnior, Juracy
dc.creatorMachado, Tales Mota
dc.creatorHitchings, Matt D. T.
dc.creatorDorion, Murilo
dc.creatorLind, Margaret L.
dc.creatorPenna, Gerson O.
dc.creatorCummings, Derek A. T.
dc.creatorDean, Natalie E.
dc.creatorWerneck, Guilherme Loureiro
dc.creatorPearce, Neil
dc.creatorBarreto, Mauricio L.
dc.creatorKo, Albert I.
dc.creatorCroda, Julio
dc.creatorBarral-Netto, Manoel
dc.date.accessioned2022-04-05T13:31:12Z
dc.date.accessioned2023-09-05T11:48:31Z
dc.date.available2022-04-05T13:31:12Z
dc.date.available2023-09-05T11:48:31Z
dc.date.created2022-04-05T13:31:12Z
dc.date.issued2022
dc.identifierSILVA, Thiago Cerqueira et.al. Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study. The Lancet Infectious Diseases, p. 1-11, 2022.
dc.identifier1474-4457
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/52032
dc.identifier10.1016/S1473-3099(22)00140-2
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8642314
dc.languageeng
dc.publisherElsevier
dc.rightsopen access
dc.titleEffectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
dc.typeArticle


Este ítem pertenece a la siguiente institución